BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raschellà G, Melino G, Gambacurta A. Cell death in cancer in the era of precision medicine. Genes Immun 2019;20:529-38. [PMID: 30341419 DOI: 10.1038/s41435-018-0048-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Brunner T. Ecto-calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma: by Paola Giglio and colleagues, Genes and Immunity, October 4, 2018. Genes Immun 2019;20:527-8. [DOI: 10.1038/s41435-018-0054-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Yan Y, Liu X, Gao J, Wu Y, Li Y. Inhibition of TGF-β Signaling in Gliomas by the Flavonoid Diosmetin Isolated from Dracocephalum peregrinum L. Molecules 2020;25:E192. [PMID: 31906574 DOI: 10.3390/molecules25010192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zoppoli P, Calice G, Laurino S, Ruggieri V, La Rocca F, La Torre G, Ciuffi M, Amendola E, De Vita F, Petrillo A, Napolitano G, Falco G, Russi S. TRPV2 Calcium Channel Gene Expression and Outcomes in Gastric Cancer Patients: A Clinically Relevant Association. J Clin Med 2019;8:E662. [PMID: 31083561 DOI: 10.3390/jcm8050662] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
4 Uchino K, Vu Quang L, Mizuno S, Horio T, Yamamoto H, Hanamura I, Kodera Y, Luis Espinoza J, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Doki N, Miyamura K, Mori T, Morishita E, Nakao S, Takami A. Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation. Genes Immun 2021;22:35-43. [PMID: 33627833 DOI: 10.1038/s41435-021-00122-y] [Reference Citation Analysis]
5 Modica C, Gallo S, Chiriaco C, Spilinga M, Comoglio PM, Crepaldi T, Basilico C, Vigna E. Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody. Cancers (Basel) 2020;12:E741. [PMID: 32245152 DOI: 10.3390/cancers12030741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]